Morgan Stanley Ice Cure Medical Ltd. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Morgan Stanley holds 6,069 shares of ICCM stock, worth $7,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,069
Previous 6,069
-0.0%
Holding current value
$7,586
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ICCM
# of Institutions
14Shares Held
154KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X058.9KShares$73,5820.01% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$50,5660.0% of portfolio
-
Two Sigma Securities, LLC New York, NY17KShares$21,2430.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.9KShares$13,6250.0% of portfolio
-
Concurrent Investment Advisors, LLC Tampa, FL10KShares$12,5000.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $46M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.